Company profile: HTG Molecular
1.1 - Company Overview
Company description
- Provider of assays and reagent systems for gene expression analysis, including the HTG Transcriptome Panel for full transcriptome profiling to support drug and companion diagnostic discovery; HTG EpiEdgeSeq for RNA modification profiling; and a Drug Discovery Engine and pipeline targeting RNAβModifying Proteins across oncology, autoimmune, neurodegenerative, and rare diseases.
Products and services
- Drug Discovery Engine: Computationally integrated system that combines transcriptome mining with medicinal chemistry and computational filters to screen molecular targets for disease research
- HTG EpiEdgeSeq: Epitranscriptomic technology that profiles RNA modifications by analyzing epitranscriptomic data, aiding drug discovery through characterization of RNA modification patterns
- HTG Transcriptome Panel: Full-transcriptome panel that profiles the entire transcriptome to support drug and companion diagnostic discovery across various disease areas
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to HTG Molecular
Teknova
HQ: United States
Website
- Description: Provider of biotechnology services, including DNA sequencing, clone testing, and clone-based crop research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Teknova company profile β
Guide Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology solutions addressing delivery of genetic therapies, leveraging patented technologies to test thousands of chemically distinct nanoparticles in vivo to identify simple, scalable, clinically relevant nanoparticles that target new cell types efficiently and safely.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Guide Therapeutics company profile β
Homology Medicines
HQ: United States
Website
- Description: Provider of genetic medicines for rare genetic diseases, leveraging a proprietary human hematopoietic stem cell-derived adeno-associated virus platform; developing Bempikibart (ADX-914), a fully human anti-IL-7RΞ± antibody to regulate adaptive immune function in Phase 2 for atopic dermatitis and alopecia areata, and ADX-097, a tissue-targeted complement regulator in Phase 2 for renal disorders and ANCA-Associated Vasculitis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Homology Medicines company profile β
Syngenta
HQ: Switzerland
Website
- Description: Provider of agricultural technologies and solutions that improve yields, crop resilience, and resource conservation. Offers crop protection from sowing to harvest; seeds and traits for grains, oilseeds, vegetables, fruits, and flowers; TYMIRIUM technology against nematodes and soil-borne pathogens; PERGADO Ultra fungicide for cocoa; and Shoots by Syngenta, a collaborative platform advancing sustainable agriculture.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Syngenta company profile β
Neogen
HQ: United States
Website
- Description: Provider of food and animal safety products, developing, manufacturing and marketing a diverse line dedicated to food and animal safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Neogen company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for HTG Molecular
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to HTG Molecular
2.2 - Growth funds investing in similar companies to HTG Molecular
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for HTG Molecular
4.2 - Public trading comparable groups for HTG Molecular
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β